Literature DB >> 16902838

Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

S C Chen1, W Chen, W H Hsu, Y H Yu, C M Shih.   

Abstract

The aim of this study was to determine whether pleural fluid C-reactive protein (CRP) is useful in distinguishing complicated parapneumonic pleural effusion (CPPE) and empyema from uncomplicated parapneumonic pleural effusions (UPPE). A total of 69 consecutive patients with parapneumonic effusions were enrolled in the study: 29 with UPPE, 29 with CPPE, and 11 with empyema. Concentrations of standard biochemical parameters together with CRP in the pleural fluid were measured using an immunoturbidimetric assay. Pleural CRP was significantly higher in CPPE (11.6 mg/dl) and in empyema (12.2 mg/dl) than in UPPE (3.9 mg/dl). A cutoff value of 8.7 mg/dl for pleural CRP in the diagnosis of CPPE and empyema resulted in a sensitivity, specificity, and area under the receiver-operating characteristic curve (AUC) of 0.80, 0.97 and 0.94, respectively. Traditional lactic dehydrogenase (LDH) > or = 1000 U/L and glucose < or = 60 mg/dl can differentiate CPPE and empyema from UPPE, with the sensitivity, specificity, and AUC achieving 0.75/0.60.1.00/1.00,0.95/0.22, respectively. However, for the detection of CPPE and empyema, the combination of pleural fluid CRP > or = 8.7 mg/dl and LDH > or = 1000 U/L was valuable in achieving a sensitivity, specificity, and AUC of 0.97/1,00/0.95. This study suggests that measurement of pleural CRP can be useful in the workup of patients with a parapneumonic effusion in order to differentiate CPPE from UPPE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902838     DOI: 10.1007/s00408-005-2573-0

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  17 in total

1.  Role of tumor necrosis factor-alpha in the differential diagnosis of parapneumonic effusion.

Authors:  M Odeh; E Sabo; A Oliven; I Srugo
Journal:  Int J Infect Dis       Date:  2000       Impact factor: 3.623

Review 2.  A new classification of parapneumonic effusions and empyema.

Authors:  R W Light
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

Review 3.  Parapneumonic effusion and empyema.

Authors:  H Hamm; R W Light
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

Review 4.  Indications for draining a parapneumonic effusion: an evidence-based approach.

Authors:  J E Heffner
Journal:  Semin Respir Infect       Date:  1999-03

5.  Evaluation of inflammatory cytokines in malignant and benign pleural effusions.

Authors:  M G Alexandrakis; S A Coulocheri; D Bouros; K Mandalaki; N Karkavitsas; G D Eliopoulos
Journal:  Oncol Rep       Date:  2000 Nov-Dec       Impact factor: 3.906

Review 6.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

7.  Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.

Authors:  J E Heffner; L K Brown; C Barbieri; J M DeLeo
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

8.  Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.

Authors:  José Manuel Porcel; Manuel Vives; Aureli Esquerda
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

9.  Parapneumonic effusions.

Authors:  R W Light; W M Girard; S G Jenkinson; R B George
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Diagnostic value of C-reactive protein in exudative pleural effusions.

Authors:  E Garcia-Pachon; I Llorca
Journal:  Eur J Intern Med       Date:  2002-06       Impact factor: 4.487

View more
  8 in total

1.  The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions.

Authors:  Servet Kayhan; Aziz Gumus; Halit Cinarka; Naci Murat; Adnan Yilmaz; Recep Bedir; Unal Sahin
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  Diagnostic accuracy of tumour markers in serous effusions: a validation study.

Authors:  Jaume Trapé; Rafael Molina; Francesc Sant; Jesús Montesinos; Anna Arnau; Josefina Franquesa; Rosana Blavia; Esperanza Martín; Emili Marquilles; Damià Perich; Concepción Pérez; Josep Maria Roca; Montserrat Doménech; Joan López; Josep Miquel Badal
Journal:  Tumour Biol       Date:  2012-06-08

3.  A persistently elevated C-reactive protein level in pneumonia may indicate empyema.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2008       Impact factor: 9.097

4.  Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.

Authors:  Dajiang Li; Yongchun Shen; Jiangyue Qin; Chun Wan; Ni Zeng; Lei Chen; Yue Dong
Journal:  Ann Transl Med       Date:  2019-01

5.  Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions.

Authors:  Chang Dong Yeo; Jin Woo Kim; Mi Ran Cho; Ji Young Kang; Seung Joon Kim; Young Kyoon Kim; Sang Haak Lee; Chan Kwon Park; Sang Ho Kim; Mi Sun Park; Hyeon Woo Yim; Jong Y Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-12-24

6.  Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Authors:  Jaume Trapé; Francesc Sant; Josefina Franquesa; Jesús Montesinos; Anna Arnau; Maria Sala; Oscar Bernadich; Esperanza Martín; Damià Perich; Concha Pérez; Joan Lopez; Sandra Ros; Enrique Esteve; Rafael Pérez; Jordi Aligué; Gabriel Gurt; Silvia Catot; Montserrat Domenech; Joan Bosch; Josep Miquel Badal; Mariona Bonet; Rafael Molina; Josep Ordeig
Journal:  Respir Res       Date:  2017-05-25

7.  Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature.

Authors:  Satish Maharaj; Carmen Isache; Karan Seegobin; Simone Chang; Grant Nelson
Journal:  Case Rep Infect Dis       Date:  2017-05-17

8.  Diagnosis of Parapneumonia Pleural Effusion with Serum and Pleural Fluid Cell-Free DNA.

Authors:  Chih-Min Su; Chia-Te Kung; Sheng-Yuan Hsiao; Nai-Wen Tsai; Yun-Ru Lai; Chih-Cheng Huang; Hung-Chen Wang; Wei-Che Lin; Ben-Chung Cheng; Yu-Jih Su; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2019-03-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.